Find a Tender · Contract
NP33923 Ranibizumab
A public procurement published by The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") via Find a Tender.
- —
- Award value
- £11.6m
- Tender value
- 4
- Suppliers
- 4
- Awards
- 2
- Notices
- Contract
- Stage
Overview
Supply of ranibizumab injections to NHS Scotland
Key details
- Source
- Find a Tender
- Lifecycle stage
- Contract
- Status
- active
- CPV classification
- 33600000 — Pharmaceutical products
- Currency
- GBP
- Total award value
- —
- Tender value
- £11,600,000
- First published
- 18 Apr 2023
- Last updated
- 27 Jul 2023
Awards
4 awards recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Teva UK Limited | 00302461 | — | active | — |
| Biogen Idec Ltd | 01497267 | — | active | — |
| Thornton & Ross | 00185947 | — | active | — |
| Novartis Pharmaceuticals UK Ltd | 00119006 | — | active | — |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
FAQs about this procurement
Who is the buyer for "NP33923 Ranibizumab"?
NP33923 Ranibizumab is a UK public-sector procurement published by The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") via Find a Tender.
Has "NP33923 Ranibizumab" been awarded?
Yes — 4 awards are recorded, with a reported total value of £11,600,000. The current lifecycle stage is "Contract".
Which suppliers are involved in "NP33923 Ranibizumab"?
4 suppliers are linked: Teva UK Limited, Biogen Idec Ltd, Thornton & Ross, Novartis Pharmaceuticals UK Ltd.
What is "NP33923 Ranibizumab" worth?
The reported tender value is £11,600,000.
When was "NP33923 Ranibizumab" published?
It was first published on 18 Apr 2023 and last updated on 27 Jul 2023, across 2 notices.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable